SCHEMBL3203974

SCHEMBL3203974

CC1=C(C)C(C)C(c2ccc3ccccc3c2CNc2c(C)cc(C)cc2C)=C1C

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.38
KMT2A Q03164 8/20 0.38
CYP1A2 P05177 2/20 0.36
CYP2A6 P11509 1/20 0.36
ALDH1A1 P00352 3/20 0.31
GAA P10253 3/20 0.31
ALOX12 P18054 2/20 0.31
HIF1A Q16665 1/20 0.31
PHLPP2 Q6ZVD8 1/20 0.31
HSD17B10 Q99714 1/20 0.31
NR3C1 P04150 1/20 0.30
PGR P06401 1/20 0.30
NR3C2 P08235 1/20 0.30
KDM4E B2RXH2 3/20 0.30
MAPT P10636 3/20 0.30
HPGD P15428 2/20 0.30
ALOX15 P16050 1/20 0.30
HTT P42858 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3199952 0.83 ALDH1A1 (0.41) MEN1KMT2ACYP1A2ALDH1A1GAA
SCHEMBL3203480 0.83 MEN1 (0.38) MEN1KMT2ACYP1A2CYP2A6ALDH1A1
Hydrochloric Acid SCHEMBL3259732 0.83 CYP1A2 (0.33) CYP1A2CYP2A6
SCHEMBL3201382 0.79 KMT2A (0.36) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL3210233 0.78 GAA (0.42) MEN1KMT2ACYP1A2ALDH1A1GAA
Hydrochloric Acid SCHEMBL3259731 0.78 CYP1A2 (0.35) MEN1KMT2ACYP1A2CYP2A6KDM4E
SCHEMBL3197846 0.76 HSD17B10 (0.36) MEN1KMT2ACYP1A2CYP2A6ALDH1A1
SCHEMBL3673721 0.76 SLC2A1 (0.37) MEN1KMT2ACYP1A2GAAHSD17B10
SCHEMBL3205798 0.76 MEN1 (0.39) MEN1KMT2ACYP1A2CYP2A6ALDH1A1
SCHEMBL3214856 0.75 MEN1 (0.38) MEN1KMT2ACYP1A2CYP2A6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732643-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-08 US disclosed
US-7671226-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-03-02 US disclosed
US-20100048933-A1 TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME HANAOKA HIDENORI 2010-02-25 US disclosed
EP-1426379-B1 TRANSITION METAL COMPLEX,CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME SUMITOMO CHEMICAL CO (JP) 2009-11-11 EP disclosed
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same HANAOKA HIDENORI 2009-02-26 US disclosed
US-7439379-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL CO., LTD. (JP) 2008-10-21 US disclosed
US-20040242410-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-12-02 US disclosed
EP-1426379-A1 TRANSITION METAL COMPLEX,CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME Sumitomo Chemical Company, Limited (JP) 2004-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same C1R, C1S, AP1M1 MEN1 1101/4885KMT2A 2101/4885CYP1A2 315/4885
US-20100048933-A1 TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME C1R, C1S, AP1M1 MEN1 1101/4885KMT2A 2101/4885CYP1A2 315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.